The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye - Trial NCT06043908
Access comprehensive clinical trial information for NCT06043908 through Pure Global AI's free database. This Phase 4 trial is sponsored by Peking University Third Hospital and is currently Recruiting. The study focuses on Dry Eye. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Peking University Third Hospital
Timeline & Enrollment
Phase 4
Aug 31, 2022
Dec 31, 2023
Primary Outcome
ocular surface disease index (OSDI),Tear break-up time (TBUT)(s),Corneal fluorescein staining (CFS),Schirmer I test (SIt) (mm/5 minutes),Lissamine green staining
Summary
The purpose of this study is to observe the effect of 0.05% cyclosporine eyedrops combined
 with artificial tears in patients with dry eyes after corneal refractive surgery and to
 observe the changes in ocular surface characteristics and tear inflammatory cytokines before
 and after treatment.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06043908
Non-Device Trial